Connor, Clark & Lunn Investment Management (CC&L)’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-12,889
Closed -$401K 1043
2017
Q1
$401K Buy
12,889
+500
+4% +$16.9K ﹤0.01% 675
2016
Q4
$433K Sell
12,389
-2,500
-17% -$79.2K ﹤0.01% 630
2016
Q3
$465K Buy
14,889
+200
+1% +$5.15K ﹤0.01% 592
2016
Q2
$340K Buy
14,689
+3,989
+37% +$94.9K ﹤0.01% 655
2016
Q1
$261K Buy
10,700
+2,700
+34% +$65.3K ﹤0.01% 675
2015
Q4
$207K Buy
+8,000
New +$197K ﹤0.01% 699

Other funds holding NUTR

Connor, Clark & Lunn Investment Management (CC&L)'s NUTR Position: Q2 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Nutraceutical International Co (NUTR) in Q2 2017, closing a stake of 12,889 shares — an estimated $401K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NUTR in Q4 2015 and held it in 6 quarters. The position peaked at $465K in Q3 2016. 86 funds tracked by Wall St. Rank hold NUTR as of Q2 2017.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Nutraceutical International Co position as of Q2 2017 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 12,889 Nutraceutical International Co shares in Q2 2017, an estimated $401K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Nutraceutical International Co in Q4 2015 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Nutraceutical International Co position peaked at $465K in Q3 2016.
  • 86 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q2 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2017, filed 14 Aug 2017.